SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000020
Filing Date
2021-03-11
Accepted
2021-03-11 08:08:51
Documents
4
Period of Report
2021-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx31121.htm 8-K 34311
2 EX-99.1 ex991-31121.htm EX-99.1 20837
3 bvlogo1.jpg GRAPHIC 8467
4 phasebio2020logo1.jpg GRAPHIC 27705
  Complete submission text file 0001169245-21-000020.txt   106585
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 21731903
SIC: 2834 Pharmaceutical Preparations